PRRG4: A Potential Drug Target and Biomarker (G79056)

Target Name: PRRG4

NCBI ID: G79056

PRRG4

PRRG4: A Potential Drug Target and Biomarker

PRRG4, also known as PRGP4, is a protein that is expressed in various tissues of the body, including the lungs, heart, kidneys, and intestines. It is a member of the PRG family, which includes proteins that are involved in the formation of tight junctions, which are a type of barrier that separates cells in the body. PRRG4 is thought to play a role in the regulation of cell-cell adhesion and has been shown to be involved in a variety of physiological processes, including tissue repair and regeneration.

In recent years, researchers have been interested in studying PRRG4 as a potential drug target. This is because the protein has been shown to be involved in the development and progression of a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Additionally , PRRG4 has been shown to be overexpressed in a variety of diseases, which suggests that it may be a useful biomarker for these conditions.

One of the potential reasons why PRRG4 has been targeted as a drug target is its role in the regulation of cell-cell adhesion. tight junctions are critical for the integrity of tissues and are involved in many physiological processes, including the development and maintenance of tissues such as the skin and the blood vessels. PRRG4 is thought to be involved in the regulation of tight junction formation and may be a useful target for drugs that are designed to disrupt these processes.

In addition to its role in cell-cell adhesion, PRRG4 is also thought to be involved in the regulation of cell proliferation. Studies have shown that PRRG4 is involved in the development and progression of a variety of cancer types, including breast, ovarian, and colorectal cancer. Additionally, PRRG4 has been shown to be involved in the regulation of cell cycle progression, which is the process by which cells grow and divide.

Another potential reason why PRRG4 has been targeted as a drug target is its role in tissue repair and regeneration. PRRG4 is thought to be involved in the regulation of the wound healing process, which is the process by which the body repairs damaged tissue and promotes the growth of new tissue. Additionally, PRRG4 has been shown to be involved in the regulation of tissue regeneration after injury or transplantation, which suggests that it may be a useful target for drugs that are designed to promote tissue repair and regeneration.

In addition to its role in regulation of cell-cell adhesion, PRRG4 is also thought to be involved in the regulation of cell signaling pathways. Studies have shown that PRRG4 is involved in the regulation of several signaling pathways, including the TGF-β pathway and the Wnt pathway. TGF-β is a signaling pathway that is involved in the regulation of cell growth, differentiation, and repair, and is thought to play a role in the development and progression of many diseases. is involved in the regulation of cell growth and development, and is also thought to be involved in the development and progression of many diseases. PRRG4 is thought to be involved in the regulation of these pathways, which suggests that it may be a useful target for drugs that are designed to disrupt these processes.

In conclusion, PRRG4 is a protein that is involved in a variety of physiological processes and has been shown to be involved in the development and progression of many diseases. As a result, PRRG4 has been targeted as a potential drug target and biomarker. Further research is needed to fully understand the role of PRRG4 in these processes and to develop effective treatments for diseases that are caused by its dysfunction.

Protein Name: Proline Rich And Gla Domain 4

Functions: May control axon guidance across the CNS (PubMed:28859078). Prevents the delivery of ROBO1 at the cell surface and down-regulates its expression (PubMed:28859078)

The "PRRG4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRRG4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets